These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2153423

  • 1. Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines.
    De Benedetti F, Falk LA, Ellingsworth LR, Ruscetti FW, Faltynek CR.
    Blood; 1990 Feb 01; 75(3):626-32. PubMed ID: 2153423
    [Abstract] [Full Text] [Related]

  • 2. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R, Takeda K, Nagumo M, Konno K.
    J Immunol; 1990 Feb 15; 144(4):1311-6. PubMed ID: 2105994
    [Abstract] [Full Text] [Related]

  • 3. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
    Kerangueven F, Sempere C, Tabilio A, Mannoni P.
    Eur Cytokine Netw; 1990 Feb 15; 1(2):99-107. PubMed ID: 2129395
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of post-transfusional hepatitis in acute myelogenous leukemia may be mediated by lipopolysaccharides, tumor necrosis factor alpha and interferon gamma.
    Treon SP, Broitman SA.
    Leukemia; 1992 Oct 15; 6(10):1036-42. PubMed ID: 1405756
    [Abstract] [Full Text] [Related]

  • 5. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG.
    Cancer Res; 1994 Aug 15; 54(16):4508-15. PubMed ID: 7519122
    [Abstract] [Full Text] [Related]

  • 6. Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor: synergistic actions with interferon-gamma and 1,25-dihydroxyvitamin D3.
    Weinberg JB, Larrick JW.
    Blood; 1987 Oct 15; 70(4):994-1002. PubMed ID: 2820533
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y, Makishima M, Kanatani Y, Kasukabe T, Honma Y.
    Exp Hematol; 1996 May 15; 24(6):682-9. PubMed ID: 8635523
    [Abstract] [Full Text] [Related]

  • 12. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 13. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T, Sonoda Y, Kuzuyama Y, Inazawa J, Kimura S, Nakamichi K, Abe T.
    Exp Hematol; 1992 Nov 01; 20(10):1201-7. PubMed ID: 1385197
    [Abstract] [Full Text] [Related]

  • 14. The type B receptor for tumor necrosis factor-alpha mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells.
    Greenblatt MS, Elias L.
    Blood; 1992 Sep 01; 80(5):1339-46. PubMed ID: 1325213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines.
    Depraetere S, Vanhaesebroeck B, Fiers W, Willems J, Joniau M.
    J Leukoc Biol; 1995 Jan 01; 57(1):141-51. PubMed ID: 7829967
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Opposite sensitivity to the antiproliferative action of interferon-alpha and granulocyte-macrophage colony-stimulating factor in monoblastic U937 cells.
    Kloke O, Moritz T, Kummer G, Hust H, Ross B, Seeber S, Niederle N.
    J Interferon Res; 1992 Oct 01; 12(5):369-76. PubMed ID: 1431316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.